ALMIRALL S.A.
Equibles does not estimate personal net worth.
Carl Sigavara has spoken on 1 earnings call across 1 company, most recently for ALMIRALL S.A. on July 24, 2026. ALMIRALL S.A. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“On this slide, I would like to focus on the early and mid-stage pipeline as a source of future value iteration and upcoming clinical inflection points. Today, we have four proof of concept of phase two studies ongoing with two additional studies planned to start towards the end of this year.”
ALMIRALL S.A.
Transcript header (unverified)
ALMIRALL S.A.
Drug Manufacturers - Specialty & Generic · Healthcare
H1 2026 Financial Results
ALMIRALL S.A.
